Response to "Considerations for integrating SGLT2 inhibitors into systemic lupus erythematosus management: Opportunities and challenges" by Chen et al. - Sagy I; Shitrit IB; Abuhasira R; David RB; Haviv YS; Tayer-Shifman O; Abu-Shakra M; Brav E; Burrack N; Zeller L (Seminars in arthritis and rheumatism, 2025)